Yvonne Greenstreet L's most recent trade in Alnylam Pharmaceuticals Inc was a trade of 14,252 Common Stock done . Disclosure was reported to the exchange on Aug. 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2025 | 14,252 | 63,200 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 454.04 per share. | 15 Aug 2025 | 2,716 | 57,485 (0%) | 0% | 454.0 | 1,233,173 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 452.96 per share. | 15 Aug 2025 | 1,646 | 60,201 (0%) | 0% | 453.0 | 745,572 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 454.84 per share. | 15 Aug 2025 | 1,204 | 56,281 (0%) | 0% | 454.8 | 547,627 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 451.99 per share. | 15 Aug 2025 | 514 | 61,847 (0%) | 0% | 452.0 | 232,323 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 449.92 per share. | 15 Aug 2025 | 450 | 62,556 (0%) | 0% | 449.9 | 202,464 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 450.92 per share. | 15 Aug 2025 | 195 | 62,361 (0%) | 0% | 450.9 | 87,929 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 447.98 per share. | 15 Aug 2025 | 194 | 63,006 (0%) | 0% | 448.0 | 86,908 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 455.82 per share. | 15 Aug 2025 | 60 | 56,221 (0%) | 0% | 455.8 | 27,349 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 304.00 per share. | 30 May 2025 | 25,469 | 55,119 (0%) | 0% | 304 | 7,742,576 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2025 | 19,559 | 8,064 | - | - | Stock Option (right to buy) | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 118.05 per share. | 30 May 2025 | 19,559 | 80,588 (0%) | 0% | 118.1 | 2,308,940 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 306.00 per share. | 30 May 2025 | 19,297 | 48,948 (0%) | 0% | 306 | 5,904,882 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 119.13 per share. | 30 May 2025 | 12,081 | 61,029 (0%) | 0% | 119.1 | 1,439,210 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2025 | 12,081 | 12,919 | - | - | Stock Option (right to buy) | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2025 | 12,080 | 839 | - | - | Stock Option (right to buy) | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 119.13 per share. | 30 May 2025 | 12,080 | 61,028 (0%) | 0% | 119.1 | 1,439,090 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 118.05 per share. | 30 May 2025 | 7,217 | 68,245 (0%) | 0% | 118.1 | 851,967 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2025 | 7,217 | 847 | - | - | Stock Option (right to buy) | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 306.00 per share. | 30 May 2025 | 6,171 | 48,948 (0%) | 0% | 306 | 1,888,326 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 16 May 2025 | 8,376 | 48,948 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 02 May 2025 | 41,311 | 57,324 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 36,293 | 36,293 | - | - | Stock Option (right to buy) | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 17,965 | 102,512 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 243.36 per share. | 03 Mar 2025 | 1,173 | 100,271 (0%) | 0% | 243.4 | 285,461 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 242.37 per share. | 03 Mar 2025 | 1,068 | 101,444 (0%) | 0% | 242.4 | 258,851 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 244.41 per share. | 03 Mar 2025 | 791 | 99,480 (0%) | 0% | 244.4 | 193,328 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 245.26 per share. | 03 Mar 2025 | 580 | 98,900 (0%) | 0% | 245.3 | 142,251 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 246.18 per share. | 03 Mar 2025 | 238 | 98,662 (0%) | 0% | 246.2 | 58,591 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 247.35 per share. | 03 Mar 2025 | 23 | 98,639 (0%) | 0% | 247.3 | 5,689 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 248.25 per share. | 03 Mar 2025 | 4 | 98,635 (0%) | 0% | 248.3 | 993 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 5,921 | 87,447 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 5,921 | 5,921 | - | - | Restricted Stock Units | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 242.44 per share. | 27 Feb 2025 | 1,093 | 85,201 (0%) | 0% | 242.4 | 264,987 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 241.51 per share. | 27 Feb 2025 | 461 | 86,294 (0%) | 0% | 241.5 | 111,336 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 243.23 per share. | 27 Feb 2025 | 440 | 84,761 (0%) | 0% | 243.2 | 107,021 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 240.32 per share. | 27 Feb 2025 | 284 | 86,755 (0%) | 0% | 240.3 | 68,251 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 244.11 per share. | 27 Feb 2025 | 214 | 84,547 (0%) | 0% | 244.1 | 52,240 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 236.51 per share. | 27 Feb 2025 | 158 | 87,289 (0%) | 0% | 236.5 | 37,369 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 239.18 per share. | 27 Feb 2025 | 127 | 87,039 (0%) | 0% | 239.2 | 30,376 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 238.33 per share. | 27 Feb 2025 | 123 | 87,166 (0%) | 0% | 238.3 | 29,315 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 3,859 | 82,739 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 253.37 per share. | 13 Feb 2025 | 300 | 82,168 (0%) | 0% | 253.4 | 76,011 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 252.50 per share. | 13 Feb 2025 | 271 | 82,468 (0%) | 0% | 252.5 | 68,428 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 254.35 per share. | 13 Feb 2025 | 201 | 81,967 (0%) | 0% | 254.3 | 51,124 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 256.29 per share. | 13 Feb 2025 | 98 | 81,784 (0%) | 0% | 256.3 | 25,116 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 255.56 per share. | 13 Feb 2025 | 85 | 81,882 (0%) | 0% | 255.6 | 21,723 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 258.07 per share. | 13 Feb 2025 | 59 | 81,678 (0%) | 0% | 258.1 | 15,226 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 257.51 per share. | 13 Feb 2025 | 47 | 81,737 (0%) | 0% | 257.5 | 12,103 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 261.45 per share. | 13 Feb 2025 | 47 | 81,572 (0%) | 0% | 261.4 | 12,288 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 260.58 per share. | 13 Feb 2025 | 38 | 81,619 (0%) | 0% | 260.6 | 9,902 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 264.88 per share. | 13 Feb 2025 | 25 | 81,526 (0%) | 0% | 264.9 | 6,622 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 259.71 per share. | 13 Feb 2025 | 21 | 81,657 (0%) | 0% | 259.7 | 5,454 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 263.33 per share. | 13 Feb 2025 | 21 | 81,551 (0%) | 0% | 263.3 | 5,530 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne Greenstreet L | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2024 | 10,658 | 84,099 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Greenstreet Yvonne L | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 251.42 per share. | 25 Nov 2024 | 2,933 | 79,180 (0%) | 0% | 251.4 | 737,415 | Common Stock |
| Alnylam Pharmaceuticals Inc | Greenstreet L Yvonne | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 250.68 per share. | 25 Nov 2024 | 1,131 | 82,113 (0%) | 0% | 250.7 | 283,519 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 249.60 per share. | 25 Nov 2024 | 762 | 83,244 (0%) | 0% | 249.6 | 190,195 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne Greenstreet L | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 252.27 per share. | 25 Nov 2024 | 300 | 78,880 (0%) | 0% | 252.3 | 75,681 | Common Stock |
| Alnylam Pharmaceuticals Inc | Greenstreet L Yvonne | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 247.77 per share. | 25 Nov 2024 | 93 | 84,006 (0%) | 0% | 247.8 | 23,043 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 280.00 per share. | 20 Aug 2024 | 15,000 | 73,441 (0%) | 0% | 280 | 4,200,000 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 85.00 per share. | 20 Aug 2024 | 15,000 | 88,441 (0%) | 0% | 85 | 1,275,000 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2024 | 15,000 | 2,352 | - | - | Stock Option (right to buy) | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 270.00 per share. | 01 Aug 2024 | 15,148 | 73,441 (0%) | 0% | 270 | 4,089,960 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 85.00 per share. | 01 Aug 2024 | 15,148 | 88,589 (0%) | 0% | 85 | 1,287,580 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 15,148 | 17,352 | - | - | Stock Option (right to buy) | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 261.00 per share. | 11 Jul 2024 | 7,093 | 73,441 (0%) | 0% | 261 | 1,851,273 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2024 | 16,953 | 88,835 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 229.93 per share. | 24 Jun 2024 | 1,572 | 84,579 (0%) | 0% | 229.9 | 361,450 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 229.06 per share. | 24 Jun 2024 | 1,374 | 86,151 (0%) | 0% | 229.1 | 314,728 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 232.54 per share. | 24 Jun 2024 | 1,119 | 82,949 (0%) | 0% | 232.5 | 260,212 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 234.66 per share. | 24 Jun 2024 | 957 | 81,397 (0%) | 0% | 234.7 | 224,570 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 235.19 per share. | 24 Jun 2024 | 863 | 80,534 (0%) | 0% | 235.2 | 202,969 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 228.30 per share. | 24 Jun 2024 | 666 | 87,525 (0%) | 0% | 228.3 | 152,048 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 233.53 per share. | 24 Jun 2024 | 595 | 82,354 (0%) | 0% | 233.5 | 138,950 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 231.59 per share. | 24 Jun 2024 | 511 | 84,068 (0%) | 0% | 231.6 | 118,342 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 221.71 per share. | 24 Jun 2024 | 308 | 88,527 (0%) | 0% | 221.7 | 68,287 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 226.82 per share. | 24 Jun 2024 | 177 | 88,191 (0%) | 0% | 226.8 | 40,147 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 225.55 per share. | 24 Jun 2024 | 93 | 88,368 (0%) | 0% | 225.5 | 20,976 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 224.17 per share. | 24 Jun 2024 | 66 | 88,461 (0%) | 0% | 224.2 | 14,795 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 46,394 | 46,394 | - | - | Stock Option (right to buy) | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 23,754 | 71,882 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2024 | 5,921 | 11,842 | - | - | Restricted Stock Units | |
| Alnylam Pharmaceuticals Inc | L Greenstreet Yvonne | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2024 | 5,921 | 51,060 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | L Greenstreet Yvonne | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 154.54 per share. | 27 Feb 2024 | 1,259 | 49,801 (0%) | 0% | 154.5 | 194,566 | Common Stock |
| Alnylam Pharmaceuticals Inc | L Greenstreet Yvonne | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 155.45 per share. | 27 Feb 2024 | 993 | 48,808 (0%) | 0% | 155.5 | 154,362 | Common Stock |
| Alnylam Pharmaceuticals Inc | L Yvonne Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 156.38 per share. | 27 Feb 2024 | 588 | 48,220 (0%) | 0% | 156.4 | 91,951 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 157.30 per share. | 27 Feb 2024 | 84 | 48,136 (0%) | 0% | 157.3 | 13,213 | Common Stock |
| Alnylam Pharmaceuticals Inc | L Greenstreet Yvonne | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 158.12 per share. | 27 Feb 2024 | 8 | 48,128 (0%) | 0% | 158.1 | 1,265 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne Greenstreet L | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 16,953 | 52,169 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Greenstreet L Yvonne | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 148.24 per share. | 15 Feb 2024 | 3,614 | 45,979 (0%) | 0% | 148.2 | 535,739 | Common Stock |
| Alnylam Pharmaceuticals Inc | L Yvonne Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 147.50 per share. | 15 Feb 2024 | 2,576 | 49,593 (0%) | 0% | 147.5 | 379,960 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne Greenstreet L | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 149.03 per share. | 15 Feb 2024 | 840 | 45,139 (0%) | 0% | 149.0 | 125,185 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 5,082 | 35,414 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 3,859 | 39,273 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 185.54 per share. | 03 Aug 2023 | 1,869 | 36,633 (0%) | 0% | 185.5 | 346,774 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 186.39 per share. | 03 Aug 2023 | 1,107 | 35,526 (0%) | 0% | 186.4 | 206,334 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 184.70 per share. | 03 Aug 2023 | 771 | 38,502 (0%) | 0% | 184.7 | 142,404 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 189.31 per share. | 03 Aug 2023 | 192 | 35,216 (0%) | 0% | 189.3 | 36,348 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 187.37 per share. | 03 Aug 2023 | 101 | 35,425 (0%) | 0% | 187.4 | 18,924 | Common Stock |
| Alnylam Pharmaceuticals Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 188.41 per share. | 03 Aug 2023 | 17 | 35,408 (0%) | 0% | 188.4 | 3,203 | Common Stock |